Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. – Cost Effective Supplements

Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/11605083

Conclusion of this study

Forty patients (2x20) were included into the study. WS1490 was superior to placebo regarding the HAMA (P=0.01) and Bf-S (P=0.002) total scores and all secondary efficacy measures. The tolerance of WS1490 was not inferior to placebo. The study confirms the anxiolytic efficacy and good tolerance of WS1490 and shows that a further symptom reduction is possible after a change-over from benzodiazepine treatment.